Intermittent Fasting with GLP-1 for Reduced Chronic Inflammation
One of the most significant health challenges of our time is chronic inflammation, which contributes to various diseases, including cardiovascular disease, arthritis, and type 2 diabetes. Intermittent fasting has been shown to have various health benefits, including weight loss, improved metabolic markers, and reduced chronic inflammation. Research suggests that combining intermittent fasting with GLP-1 (glucagon-like peptide-1) receptor agonists may have a synergistic effect in reducing chronic inflammation. In this article, we will explore the benefits of intermittent fasting with GLP-1 for reduced chronic inflammation.
What is Intermittent Fasting?
Intermittent fasting involves restricting calorie intake for certain periods, usually 16-24 hours. The most popular form of intermittent fasting is the 16:8 protocol, where you fast for 16 hours and eat within an 8-hour window. Intermittent fasting has been shown to have various health benefits, including weight loss, improved metabolic markers, and reduced systemic inflammation.
What is GLP-1?
GLP-1 is a hormone produced by the gut that helps regulate appetite, blood sugar, and metabolism. GLP-1 receptor agonists are medications that mimic the action of GLP-1, reducing hunger and increasing feelings of fullness. These medications have been shown to have various health benefits, including weight loss, improved glycemic control, and reduced cardiovascular risk.
